March 24, 2026 March 24, 2026Categories News StoriesECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk
February 27, 2026 February 27, 2026Categories AnnouncementsAttention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD, Health Equity Travel Scholarship to attend the Spring 2026 Group Meeting
February 9, 2026 February 9, 2026Categories News StoriesNatasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials
February 3, 2026 February 3, 2026Categories News StoriesECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations
January 29, 2026 January 29, 2026Categories News StoriesPress Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer
January 21, 2026 January 21, 2026Categories News StoriesECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older
January 8, 2026 January 8, 2026Categories News StoriesWATCH: Drs. Jen Specht and Heather Jacene discuss the FEATURE (EA1183) trial results…a game-changer for bone-dominant metastatic breast cancer
January 8, 2026 January 8, 2026Categories News StoriesAI models advance individualized breast cancer recurrence risk assessments
January 8, 2026 January 8, 2026Categories News StoriesCaris, cooperative groups advancing AI models that can improve breast cancer risk assessments (access requires free registration)
